Brain Infection Reports Prompt Boxed Warning On Adcetris
Federal regulators said Friday they had slapped a boxed warning on Adcetris — a lymphoma drug developed by Seattle Genetics Inc. and a Takeda Pharmaceutical Co. Ltd. subsidiary — after receiving...To view the full article, register now.
Already a subscriber? Click here to view full article